Luther King Capital Management (LKCM)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-618
Closed -$321K 596
2024
Q3
$321K Sell
618
-4
-0.6% -$2.14K ﹤0.01% 522
2024
Q2
$337K Buy
622
+16
+3% +$8.46K ﹤0.01% 508
2024
Q1
$314K Sell
606
-65
-10% -$32.3K ﹤0.01% 514
2023
Q4
$316K Buy
+671
New +$310K ﹤0.01% 507
2022
Q4
Sell
-474
Closed -$215K 584
2022
Q3
$215K Buy
+474
New +$227K ﹤0.01% 543
2022
Q2
Sell
-627
Closed -$308K 609
2022
Q1
$308K Sell
627
-5
-0.8% -$2.29K ﹤0.01% 544
2021
Q4
$293K Buy
632
+17
+3% +$7.15K ﹤0.01% 556
2021
Q3
$229K Buy
+615
New +$234K ﹤0.01% 574
2020
Q1
Sell
-745
Closed -$225K 514
2019
Q4
$225K Buy
+745
New +$205K ﹤0.01% 522
2013
Q4
Sell
-10,250
Closed -$857K 549
2013
Q3
$857K Hold
10,250
0.01% 451
2013
Q2
$839K Buy
+10,250
New +$767K 0.01% 450

Other funds holding ELV

Luther King Capital Management (LKCM)'s ELV Position: Q4 2024 in Review

Luther King Capital Management (LKCM) sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 618 shares — an estimated $321K sold.

Luther King Capital Management (LKCM) first reported a position in ELV in Q2 2013 and held it in 11 quarters. The position peaked at $857K in Q3 2013. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Luther King Capital Management (LKCM) reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 618 Elevance Health shares in Q4 2024, an estimated $321K.
  • Luther King Capital Management (LKCM) first reported a position in Elevance Health in Q2 2013 and held it in 11 quarters.
  • Luther King Capital Management (LKCM)'s Elevance Health position peaked at $857K in Q3 2013.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q4 2024, filed 7 Feb 2025.